Bank of Montreal
IMNM icon

Bank of Montreal’s Immunome IMNM Stock Holding History

Bank of Montreal’s Portfolio IMNM Stock Details IMNM Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2023
Q4 		– Sell
-92,593
Closed -$693K – 4139
2023
Q3 		$693K Sell
92,593
-7,741
-8% -$56.9K ﹤0.01% 2250
2023
Q2 		$800K Buy
100,334
+7,741
+8% +$42.3K ﹤0.01% 2309
2023
Q1 		$524K Hold
92,593
– – ﹤0.01% 2431
2022
Q4 		$416K Hold
92,593
– – ﹤0.01% 2716
2022
Q3 		$529 Hold
92,593
– – ﹤0.01% 2555
2022
Q2 		$357 Hold
92,593
– – ﹤0.01% 2900
2022
Q1 		$556K Hold
92,593
– – ﹤0.01% 2757
2021
Q4 		$1.39M Hold
92,593
– – ﹤0.01% 1779
2021
Q3 		$2.35M Buy
+92,593
New +$1.62M ﹤0.01% 1988
2021
Q2 		– Sell
-59
Closed -$2K – 4255
2021
Q1 		$2K Sell
59
-330
-85% -$8.2K ﹤0.01% 4907
2020
Q4 		$5K Buy
+389
New +$4.54K ﹤0.01% 4758

Other funds holding IMNM

Fidelity Investments
Fidelity Investments Boston, Massachusetts $1.9T AUM 41.92% 1-Year Est. Return
EC
EcoR1 Capital San Francisco, California $2.36B AUM 204.53% 1-Year Est. Return
RG
Redmile Group San Francisco, California $1.51B AUM 164.17% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Janus Henderson Group
Janus Henderson Group London, United Kingdom $209B AUM 37.72% 1-Year Est. Return
APM
Avidity Partners Management Dallas, Texas $936M AUM 195% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $865B AUM 30.76% 1-Year Est. Return
WP
Woodline Partners San Francisco, California $26.4B AUM 44.85% 1-Year Est. Return
Point72 Asset Management
Point72 Asset Management Stamford, Connecticut $78.1B AUM 55.25% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return

Bank of Montreal's IMNM Position: Q4 2023 in Review

Bank of Montreal sold out of Immunome (IMNM) in Q4 2023, closing a stake of 92,593 shares — an estimated $693K sold.

Bank of Montreal first reported a position in IMNM in Q4 2020 and held it in 11 quarters. The position peaked at $2.35M in Q3 2021. 57 funds tracked by Wall St. Rank hold IMNM as of Q4 2023.

  • Bank of Montreal reported no remaining Immunome position as of Q4 2023 after selling out during the quarter.
  • Bank of Montreal sold 92,593 Immunome shares in Q4 2023, an estimated $693K.
  • Bank of Montreal first reported a position in Immunome in Q4 2020 and held it in 11 quarters.
  • Bank of Montreal's Immunome position peaked at $2.35M in Q3 2021.
  • 57 funds tracked by Wall St. Rank held Immunome as of Q4 2023.

Based on Bank of Montreal's 13F filing for Q4 2023, filed 8 Feb 2024.